Shenzhen Capital Group
VC Fund
Shenzhen, China
Shenzhen Capital Group is a VC fund in Shenzhen focused on Manufacturing and Health Care. Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by the Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation, and emerging industries developing. SCGC has registered capital of 5.42 billion RMB,and a total AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based on the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.
- Total investments:
- 623
- Last investment:
- Lead investor:
- 41%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Shenzhen Capital Group invests in
Stages Shenzhen Capital Group invests in
Countries Shenzhen Capital Group invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 36 contacts → | |||
Round size
- Series A
- $1.5M–$128M
- Series B
- $10M–$141M
- Series C
- $4.4M–$156M
Investment Focus
Industry
- Manufacturing 106 (17%)
- Health Care 46 (7%)
- Software 42 (7%)
- Electronics 37 (6%)
- Information Technology 37 (6%)
Stage
- Series A 133 (21%)
- Series B 91 (15%)
- Series C 45 (7%)
- Seed 43 (7%)
- Funding Round 30 (5%)
Country
- China 358 (57%)
- United States 10 (2%)
- Japan 2 (0%)
- Malta 1 (0%)
- Canada 1 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Bo Sheng
General Manager of Nantong city fund
|
General Manager of Nantong city fund | Total investments: 0 | Find email | |
|
Dongsheng Sun
Group Vice President
|
Group Vice President | Total investments: 0 | Find email | |
|
Gang Liu
General Manager of Beijing city fund
|
General Manager of Beijing city fund | Total investments: 0 | Find email | |
|
Haitao Jin
Chairman
|
Chairman | Total investments: 2 | Find email | |
|
Hanxin Zhong
Head of Audit & Supervision
|
Head of Audit & Supervision | Total investments: 0 | Find email | |
| See all 36 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
ENCOS is a developer of high-performance robot integrated joint modules. The company focuses on matters of embodied intelligence, with robot reduction motors as its main business. | $44.7M / Series B / Sep 13, 2026 | |
|
|
Yeats AI is an innovative company focused on edge AI computing, dedicated to building a full-stack solution from acceleration hardware to AI algorithms, providing efficient and robust AI capabilities for next-generation smart devices. | Seed / Sep 11, 2026 | |
|
|
GeneMind Biosciences is a domestic third-generation single-molecule gene sequencing system. GeneMind Biosciences has been fighting to provide better gene sequencing solutions for clinicians and researchers. A Gene sequencer is the crown jewel in the field of gene sequencing. Entrepreneurs will lead their innovations and breakthroughs throughunremitting research and exploration. GeneMind believes that the strong pass of the difficulty is like a wall of iron, yet with firm strides, we are conquering its summit. | $89.5M / Series D / Sep 10, 2026 | |
|
|
Differential Robotics is a robotics company providing research, design, and development of aerial robots and intelligent autonomous drones. | Series A / Sep 04, 2026 | |
|
|
Kossel Medical is a medical device R&D, manufacturer of vascular interventional devices to provide clinical system solutions. | $59.5M / Series C / Sep 01, 2026 | |
|
|
Yuzhiquan is an optical precision instrument company. It is committed to providing laser direct writing and other high-end optical precision instruments and industry solutions. | Series B / Aug 31, 2026 | |
|
Fucheng Technology
|
Fucheng Technology is committed to providing high-precision general-purpose component solutions for the semiconductor equipment industry chain. | Angel / Aug 20, 2026 | |
|
|
kokoni is an innovative, user-friendly 3D printer brand owned by Moxin (Huzhou) Technology Co., LTD | $74.3M / Venture - Series Unknown / Aug 19, 2026 | |
|
|
Zillnk develops Open RAN-based wireless communications equipment and related network software for mobile networks. The company focuses on designing and manufacturing radio units that support 2G, 4G, 5G, and emerging 6G frequency bands. Its hardware portfolio includes remote radio units, active antenna units, and Massive MIMO systems tailored formacro base station deployments. Zillnk also provides programmable network automation software that handles signal processing functions and AI-driven energy optimization. These offerings are aimed at mobile operators and ecosystem partners seeking interoperable, standards-based radio access network infrastructure. Zillnk’s solutions are used in commercial and trial deployments and carry multiple international technical certifications. | $14.8M / Series B / Aug 18, 2026 | |
|
|
Garen Semiconductor focuses on the R&D, production and sales of semiconductor materials (such as gallium oxide). | Series A / Aug 13, 2026 | |
| See all 623 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Shenzhen Capital Group invest in?
Shenzhen Capital Group invests primarily in Manufacturing, Health Care and Software startups, most often at Series A and Series B stage. Most of the 623 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Shenzhen Capital Group's check size?
Shenzhen Capital Group typically joins rounds of $1.5M–$128M at Series A, $10M–$141M at Series B and $4.4M–$156M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Shenzhen Capital Group participates in.
How do I contact Shenzhen Capital Group?
Public channels for Shenzhen Capital Group include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Shenzhen Capital Group?
The team at Shenzhen Capital Group includes Bo Sheng (General Manager of Nantong city fund), Dongsheng Sun (Group Vice President) and Gang Liu (General Manager of Beijing city fund), among 36 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!